- Biogen (BIIB): Medicare proposes covering expensive drug for early-stage Alzheimer’s, but with restrictions that will sharply limit use https://www.washingtonpost.com/health/2022/01/11/alzheimers-drug-aduhelm-medicare-coverage 9 comments wallstreetbets